Revolution Medicines, Inc. (RVMDW) Net margin 2018–2023
Revolution Medicines, Inc. (RVMDW) net profit margin by fiscal year — reported net income divided by reported revenue.
-3768.3%FY2023 · since FY2018: -207.2% → -3768.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -3768.3% | -3065.3 pp |
| FY2022 | -703.0% | -66.4 pp |
| FY2021 | -636.6% | -384.9 pp |
| FY2020 | -251.6% | -156.4 pp |
| FY2019 | -95.2% | +112.0 pp |
| FY2018 | -207.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating marginRVMDW Operating cash flowRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →